9 completed, 5 unknown, 2 active not recruiting, 1 recruiting. 10 Not applicable, 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 10 | Completed 7, Unknown 3 |
| Phase 1 | 2 | Completed 1, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Gyrate Atrophy: new trials by email Literature Review of Gyrate Atrophy trials Research Report on Gyrate Atrophy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Gyrate Atrophy Ocular and Systemic Study Gyrate Atrophy, Gyrata of Choroid and Retina; Atrophy | Active not recruiting | Jaeb Center for Health Research | 46 | 2023-11-21 | 2026-10-27 | |
| Gluten Free Oat (Cultivar Saul) in Celiac Disease in Remission certified gluten-free oats of the Saul variety - Celiac Disease | Not applicable | Completed | Faculty Hospital Kralovske Vinohrady | 40 | 2022-01-07 | 2026-04-07 |
| Effect of Oat Compounds on Postprandial Glucose Response High beta glucans, Low beta glucans, Low beta glucans + low polar lipids - Healthy Subjects | Not applicable | Completed | Lund University | 20 | 2021-12-01 | 2022-01-21 |
| Meta-analysis of Oat Fiber and Cardiovascular Risk Reduction Oats or Oat Fibre - Cardiovascular Diseases, Coronary Heart Disease | Unknown | University of Toronto | 1 | 2021-11-01 | 2024-05-06 | |
| Oat and Cholesterol Active oat beverage, Control rice beverage - Elevated LDL Cholesterol | Not applicable | Completed | PepsiCo Global R&D | 207 | 2019-04-10 | 2020-03-23 |
| Early Check: Expanded Screening in Newborns Confirmatory Testing - Spinal Muscular Atrophy, Fragile X Syndrome | Active not recruiting | RTI International | 30000 | 2018-10-15 | 2026-07-01 | |
| Impact of DHA/Oat on Metabolic Health in Gestational Diabetes Mellitus DHA, oat grains - Gestational Diabetes Mellitus in Pregnancy | Not applicable | Unknown | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 80 | 2017-08-01 | 2018-06-26 |
| Chronic Cardiovascular and Gut-bacteria Effects of Phenolic Rich Oats in Adults With Above Average Blood Pressure High avenanthramide, phenolic acid, Low avenanthramide, medium phenolic acid, Control - Healthy | Not applicable | Unknown | University of Reading | 30 | 2016-07-01 | 2016-07-28 |
| Safety and Tolerability of Oat Containing Gluten-free Diet Pure, uncontaminated oats - Celiac Disease | Not applicable | Completed | Alfred Rusescu Institute for Mother and Child Care | 25 | 2015-11-01 | 2017-08-03 |
| Oat Phenolics Bioavailability Oat bran, refined grain - Healthy | Not applicable | Completed | University of Reading | 7 | 2015-07-01 | 2015-10-12 |
| Inherited Retinal Degenerative Disease Registry Eye Diseases Hereditary, Retinal Disease | Recruiting | Foundation Fighting Blindness | 20000 | 2014-06-01 | 2026-05-19 | |
| Clinical Assessment of Barley and Oat Phytochemicals Whole grain oats and barley - Healthy | Not applicable | Completed | Tufts University | 13 | 2010-09-01 | 2013-05-27 |
| Bioavailability of Avenanthramide-Enriched Oats in Healthy Older Adults Avenanthramide-enriched oats - Healthy | Not applicable | Completed | Tufts University | 12 | 2010-03-01 | 2013-05-27 |
| Oat Products in the Treatment of Coeliac Disease in Children Gluten-free products - Clinical and Nutritional Safety. | Not applicable | Unknown | Heinz Italia SpA | 300 | 2009-01-01 | 2015-03-18 |
| Gene Therapy for Gyrate Atrophy Gene therapy - Gyrate Atrophy | Phase 1 | Completed | National Eye Institute (NEI) | 5 | 1998-04-01 | 2008-03-04 |
| Gyrate Atrophy of the Choroid and Retina Gyrate Atrophy | Completed | National Eye Institute (NEI) | 65 | 1978-01-01 | 2008-03-04 | |
| Impact of Consumption of Oats in Lipid Profile of Children and Adolescents With Dyslipidemia Oat bran - Atherosclerosis, Hypercholesterolemia | Phase 1 / Phase 2 | Unknown | Instituto de Cardiologia do Rio Grande do Sul | 2012-04-20 |
Celiac Disease (3) · Hypercholesterolemia (2) · 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency (1) · 3-Hydroxyacyl-CoA Dehydrogenase Deficiency (1) · 3-methylcrotonyl CoA carboxylase 1 deficiency (1) · 3-methylcrotonyl CoA carboxylase 2 deficiency (1) · Abetalipoproteinemia (1) · Achromatopsia 3 (1) · Acidemia, isovaleric (1) · Acrodermatitis enteropathica (1) · Adenine phosphoribosyltransferase deficiency (1) · Adrenal hyperplasia, congenital, type 5 (1) · Adrenocorticotropic hormone deficiency (1) · Amaurosis congenita of Leber, type 2 (1)
Choroid Diseases (17) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (17) · Eye Diseases (17) · Genetic Diseases, Inborn (17) · Uveal Diseases (17) · Eye Diseases, Hereditary (16) · Metabolic Diseases (9) · Nutritional and Metabolic Diseases (9) · Digestive System Diseases (4) · Dyslipidemias (4) · Lipid Metabolism Disorders (4) · Pathological Conditions, Signs and Symptoms (4) · Cardiovascular Diseases (3) · Endocrine System Diseases (3) · Gastrointestinal Diseases (3)
Docosahexaenoic Acids (1) · Genetic Therapy (1) · phenolic acid (1)
National Eye Institute (NEI) (2) · Tufts University (2) · University of Reading (2) · Alfred Rusescu Institute for Mother and Child Care (1) · Faculty Hospital Kralovske Vinohrady (1) · Foundation Fighting Blindness (1) · Heinz Italia SpA (1) · Instituto de Cardiologia do Rio Grande do Sul (1) · Jaeb Center for Health Research (1) · Lund University (1) · PepsiCo Global R&D (1) · RTI International (1) · University of Toronto (1) · Xinhua Hospital, Shanghai Jiao Tong University School of Medicine (1)
United States (7) · Canada (3) · United Kingdom (3) · Brazil (2) · Italy (2) · China (1) · Czechia (1) · Finland (1) · France (1) · Germany (1) · Romania (1) · Sweden (1)
Jeffrey B Blumberg, PhD (2) · Basilio Malamisura, Prof. (1) · Carlo Catassi, Prof. (1) · Curt Scharfe, MD, PhD (1) · David Valle, MD (1) · Jeremy P Spencer, Professor (1) · John L Sievenpiper, PhD, MD (1) · Klaus Pittschieler, Prof. (1) · Mandeep S. Singh, MD (1) · Maria Barbato, Prof. (1) · Mario La Rosa, Prof. (1) · Roberto Panceri, Dr. (1) · Ruggiero Francavilla, Dr. (1) · Thomas MS Wolever, MD, PhD (1)
PMID 25687568, PMID 26771637, PMID 29478494, PMID 31315600, PMID 34236436, PMID 35142618, PMID 37020805